As expected, Supercomnet Technologies Berhad’s (Scomnet) 1QFY23 net profit of RM7.0mn came in at 17.3/17.8% of ours and consensus’s full-year estimates. We deem the results to be within expectations as we expect a better 2H23.
1Q23 net profit decreased 5.2% to RM7.0mn despite higher revenue of 3.9% to RM37.4mn. The higher revenue was driven by the automotive sector, which offset the decline in revenue from the medical segment. We attribute the weaker medical segment sales to: i) post pandemic inventories adjustments by customers and ii) weaker demand for Endoscopy Video Cables.
PBT margin contraction (-2.9pp to 24.1% YoY) was due to the lower medical segment contribution (higher margin than auto). In addition, margins were affected by the higher electricity tariff and implementation of Minimum Wages Order 2002.
QoQ, revenue was flat while PBT improved to RM9.0mn as compared to RM7.6mn in 4Q22. The better performance was on the back of higher sales of higher profit margin products from the medical segment. This led to a higher PBT margin of 3.8pp to 24.1%.
In terms of contribution, the medical segment remained the key earnings contributor to the group, accounting for 60% of sales while automotive and industrial segment accounted for 20% and 20% of revenue respectively.
Our FY23/24/25 earnings estimates are adjusted lower by 2.8/0.6/0.9% after imputing FY22 audited numbers into our model.
We remain confident that 2H23 will be better as demand for Scomnet’s products is expected to continue to increase. Note that the production setup for the non-electric syringe infusion system (with adjustable flow rate controller) is ready but the supplier issues may only be resolved in 4Q23.
Following the earnings revision, our TP is lowered to RM1.85/share (previously RM1.86/share) based on an unchanged 32.0x CY24 diluted EPS.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....